Table 3. Clinicopathological characteristics of hepatocellular carcinoma patients.
| Variables | Patients (n = 30) |
|---|---|
| Total number | |
| Age | |
| ≤55 years | 13 (43.3) |
| >55 years | 17 (56.7) |
| Sex | |
| Female | 11 (367) |
| Male | 19 (63.3) |
| Tumor size | |
| <5 cm | 9 (30.0) |
| ≥5 cm | 21 (70.0) |
| Number of lesions | |
| Solitary | 20 (66.7) |
| Multiple | 10 (33.3) |
| LCF score | 9.7±1.2 |
| CTP class | |
| Child B | 21 (70.0) |
| Child C | 9 (30.0) |
| Hepatomegaly | |
| Mild | 18 (60.0) |
| Massive | 12 (40.0) |
| Treatment | |
| Ablation | 15 (30.0) |
| Radiofrequency | 11 (36.7) |
| Supportive | 4 (13.3) |
| GAS5 fold | |
| ≤ 1-fold | 27 (90.0) |
| > 1-fold | 3 (10.0) |
| miR-34a fold | |
| ≤ 1-fold | 19 (63.3) |
| > 1-fold | 10 (33.3) |
Data are presented as number (frequency). CTP Child-Turcotte-Pugh classification for liver cell failure, LCF liver cell failure score by CTP classification. Fisher's Exact and Pearson Chi-square tests were used.